Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from LifeTech Scientific Corporation ( (HK:1302) ) is now available.
LifeTech Scientific Corporation has announced a strategic investment in Affector Medtech, a high-tech company in China specializing in electrophysiology and innovative medical devices. The investment, totaling RMB150 million, will be executed in stages and will grant LifeTech a 30% equity interest in Affector Medtech. This move is expected to enhance LifeTech’s capabilities in cardiac intervention imaging and electrophysiology, with exclusive cooperation and distribution rights for Affector’s products. The partnership aims to foster joint research and development, leveraging both companies’ strengths to advance in the medical device market.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company is particularly involved in electrophysiology and cardiac intervention imaging platforms, aiming to leverage its expertise and resources to expand its market presence.
Average Trading Volume: 21,655,464
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.57B
Find detailed analytics on 1302 stock on TipRanks’ Stock Analysis page.